33 suspended. 33 Phase 2, 8 Phase 3, 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 33 | Suspended 33 |
| Phase 3 | 8 | Suspended 8 |
| Phase 1 | 2 | Suspended 2 |
Follow Infections: new trials by email Literature Review of Infections trials Research Report on Infections
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy and Safety of SR-T100 Gel in Common Warts (CW) Patients Vehicle gel, SR-T100 gel with 1.0% of SM, SR-T100 gel with 2.3% of SM - Common Wart | Phase 2 | Suspended | G&E Herbal Biotechnology Co., LTD | 102 | 2030-09-01 | 2023-09-14 |
| Efficacy of Para-Tyrosine Supplementation on the Survival and Clinical Outcome in Patients With Sepsis Para-Tyrosine supplementation, Placebo solution - Sepsis | Phase 2 | Suspended | University of Pecs | 296 | 2027-01-01 | 2025-03-30 |
| Etoposide, Prednisone, Vincristine, Cyclophosphamide, and Doxorubicin (DA-EPOCH) With or Without Rituximab Plus Recombinant Erwinia Asparaginase (JZP458) for the Treatment of Newly Diagnosed Ph Negative B-Acute Lymphoblastic Leukemia or T Acute Lymphoblastic Leukemia Asparaginase Erwinia chrysanthemi, Biospecimen Collection, Bone Marrow Collection - B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative, T Acute Lymphoblastic Leukemia | Phase 2 | Suspended | University of Washington | 30 | 2026-05-08 | 2026-09-29 |
| ARN-75039 Lassa Fever Treatment in West Africa ARN-75039 high, Intravenous ribavirin, ARN-75039 low - Lassa Fever | Phase 2 | Suspended | Arisan Therapeutics, Inc. | 135 | 2026-02-14 | 2026-07-06 |
| A Phase 1b/2 Study of Intravenous Brincidofovir in Patients With Relapsed or Refractory Lymphoma and Relapsed or Refractory Extranodal Natural Killer/T-cell Lymphoma Brincidofovir - Relapsed or Refractory Lymphoma Including ENKL | Phase 1 / Phase 2 | Suspended | SymBio Pharmaceuticals | 43 | 2025-06-09 | 2026-02-05 |
| Trial of Novel Regimens for the Treatment of Pulmonary Tuberculosis Isoniazid, Rifampicin, Pyrazinamide - Pulmonary Tuberculosis | Phase 2 | Suspended | National Institute of Allergy and Infectious Diseases (NIAID) | 341 | 2025-03-11 | 2026-11-02 |
| A Trial to Evaluate the Safety and Efficacy of DBI-001 Gel, DBI-002 Gel, and Aqueous Gel in Subjects With Onychomycosis DBI-001, DBI-002, Aqueous Gel - Onychomycosis | Phase 2 | Suspended | DermBiont, Inc. | 60 | 2023-11-01 | 2023-09-07 |
| Immunogenicity and Safety Study of the 3rd Booster Dose Using the High or Medium Dose of Inactivated (CoronaVac®) Vaccine in Healthy Adults in Turkey Medium-dose COVID-19 Vaccine(Vero Cell),Inactivated, High-dose COVID-19 Vaccine(Vero Cell),Inactivated - COVID-19 | Phase 2 | Suspended | Sinovac Research and Development Co., Ltd. | 640 | 2022-12-15 | 2022-08-11 |
| Drug Exposure and Safety of a Shorter Tuberculosis Treatment Based on High-Dose Rifampicin and Pyrazinamide rifampicin, pyrazinamide, HRZE - Tuberculosis, Pulmonary | Phase 2 | Suspended | University Hospital, Linkoeping | 40 | 2022-11-30 | 2026-08-17 |
| Treatment of Hemorrhagic Fever With Ribavirin Virazole - Hemorrhagic Fever | Phase 2 | Suspended | U.S. Army Medical Research and Development Command | 50 | 2022-10-31 | 2026-07-07 |
| Controlled Human Malaria Infection Transmission Model - Phase A PfSPZ Challenge, Sulfadoxine-Pyrimethamine, Piperaquine - Malaria,Falciparum | Phase 1 / Phase 2 | Suspended | University of Oxford | 44 | 2022-08-22 | 2024-05-23 |
| Hemodynamics Effects of Fludrocortisone on the Pressor Response to Noradrenaline Septic Shock Patients Fludrocortisone, Placebo - Septic Shock | Phase 2 / Phase 3 | Suspended | Rennes University Hospital | 40 | 2022-03-31 | 2023-11-18 |
| A Phase Ⅱ Clinical Trial of the Recombinant Mycobacterium Tuberculosis Vaccine Freeze-dried (AEC/BC02) Low-dose freeze-dried recombinant tuberculosis vaccine (AEC / BC02), High-dose freeze-dried recombinant tuberculosis vaccine (AEC / BC02), High-dose adjuvant for freeze-dried recombinant tuberculosis vaccine (AEC / BC02) - Tuberculosis | Phase 2 | Suspended | Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. | 200 | 2022-02-10 | 2023-11-28 |
| Yinhu Qingwen Granula for the Treatment of Severe CoVID-19 Yinhu Qingwen Granula, Yin Hu Qing Wen Granula(low does), standard medical treatment - COVID-19, Severe Pneumonia | Phase 2 / Phase 3 | Suspended | Zhong Wang | 116 | 2021-11-01 | 2021-07-07 |
| Yinhu Qingwen Decoction for the Treatment of Mild / Common CoVID-19 YinHu QingWen Decoction, YinHu QingWen Decoction(low dose), Chinese medicine treatment - CoVID-19, Chinese Medicine | Phase 2 / Phase 3 | Suspended | China Academy of Chinese Medical Sciences | 300 | 2021-10-01 | 2021-07-07 |
| Safety, Tolerability and Efficacy Of S-1226 in Moderate Severity Covid-19 Bronchiolitis/Pneumonia S-1226 - Covid19, SARS-CoV-2 Infection | Phase 2 | Suspended | SolAeroMed Inc. | 30 | 2021-09-15 | 2021-08-23 |
| Fluvoxamine for Adults With Mild to Moderate COVID-19 Fluvoxamine, Placebo - Severe Acute Respiratory Syndrome Coronavirus 2, Coronavirus Infection | Phase 2 | Suspended | Asan Medical Center | 400 | 2021-01-16 | 2021-04-19 |
| CBD Oil for Reducing Emotional Impact of COVID-19 CBD Isolate, Full Spectrum CBD Oil, Broad-Spectrum CBD Oil - Anxiety Depression, Alcohol Abuse | Phase 2 / Phase 3 | Suspended | University of Texas at Austin | 200 | 2020-12-04 | 2023-11-22 |
| Decitabine for Coronavirus (COVID-19) Pneumonia- Acute Respiratory Distress Syndrome (ARDS) Treatment: DART Trial Decitabine, Placebo Saline - COVID-19 | Phase 2 | Suspended | Johns Hopkins University | 33 | 2020-09-14 | 2025-08-29 |
| Study of Immune Modulatory Drugs and Other Treatments in COVID-19 Patients: Sarilumab, Azithromycin, Hydroxychloroquine Trial - CORIMUNO-19 - VIRO Sarilumab, Azithromycin, Hydroxychloroquine - COVID19, SARS-CoV-2 Infection | Phase 2 / Phase 3 | Suspended | Assistance Publique - Hôpitaux de Paris | 27 | 2020-04-11 | 2020-05-06 |
Showing 20 of 33. Sign in to see all of them.
COVID-19 (7) · HIV Infections (5) · Hemorrhagic Fevers, Viral (2) · Malaria, Falciparum (2) · Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (2) · Sepsis (2) · Tuberculosis, Pulmonary (2) · Acquired Immunodeficiency Syndrome (1) · Alcoholism (1) · Aspergillosis (1) · Burkitt Lymphoma (1) · Cardiovascular Diseases (1) · Communicable Diseases, Emerging (1) · Coronavirus Infections (1) · Diabetes Mellitus (1)
Virus Diseases (19) · RNA Virus Infections (16) · Respiratory Tract Diseases (10) · Lung Diseases (9) · Respiratory Tract Infections (9) · Coronaviridae Infections (8) · Immune System Diseases (8) · Nidovirales Infections (8) · Communicable Diseases (7) · Coronavirus Infections (7) · Pneumonia, Viral (7) · Urogenital Diseases (7) · Bacterial Infections and Mycoses (6) · Blood-Borne Infections (6)
Ethambutol (2) · Isoniazid (2) · Nelfinavir (2) · Pyrazinamide (2) · Rifampin (2) · bedaquiline (2) · capravirine (2) · lamivudine, zidovudine drug combination (2) · Adjuvants, Pharmaceutic (1) · Artemether, Lumefantrine Drug Combination (1) · Asparaginase (1) · Azithromycin (1) · BANG polymer gel (1) · CT-P10 (1) · Cefoperazone (1)
Agouron Pharmaceuticals (2) · Assistance Publique - Hôpitaux de Paris (2) · Agennix (1) · Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. (1) · Arisan Therapeutics, Inc. (1) · Asan Medical Center (1) · Brynn Chappell (1) · China Academy of Chinese Medical Sciences (1) · DermBiont, Inc. (1) · G&E Herbal Biotechnology Co., LTD (1) · Hospital Clinic of Barcelona (1) · Izun Pharma Ltd (1) · Janssen Research & Development, LLC (1) · Johns Hopkins University (1) · Menzies School of Health Research (1)
United States (9) · China (5) · Canada (4) · France (4) · Dominican Republic (2) · Germany (2) · Israel (2) · Kenya (2) · Philippines (2) · South Africa (2) · Spain (2) · Uganda (2) · United Kingdom (2) · Belgium (1) · Botswana (1)
Jiang-Rong Huang, M.D. (2) · Xiao-Dong Li, M.D. (2) · Bruno Laviolle, MD, PhD (1) · Dong Shang, M.D. (1) · Eligius F Lyamuya, MD, MMed, PhD, FTAAS, FCPath (1) · Emiliana Tjitra, MD (1) · Emma Taylor, M.D. (1) · Felipe Garcia, MD, PhD (1) · Hamm-Ming Sheu, MD (1) · Harmonie Perrichet, MD (1) · Katarina Niward, MD, PhD (1)
PMID 23922746, PMID 26010687, PMID 35273049, PMID 35384422, PMID 36560565, PMID 38978068, PMID 40195983, PMID 40817073, PMID 40880360
2014 (1), 2019 (1), D43TW009775 (1), R25TW011227 (1)